MedTrace Logo

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

NCT03328065 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2022-04-21

No results posted yet for this study

Summary

Reflexion on the therapeutic strategies to implement in patients at the end of life is advancing rapidly in France. However, beyond the choices presented to patients, sometimes even the decision to carry on, to limit or to stop treatments is also questioned. This decision is subjective; it is influenced by the patient's representation system (emotions, beliefs, values, practices, etc). In addition, even though he or she is the focus of the decision, the patient is not alone; other actors, accompanying the patient, play an important role in the final decision making. These actors, namely the doctors and close relatives, are also influenced in their decision making. This coexistence of representation systems may interfere with objective indicators that help in decision making (functional, clinical and biological) or with the knowledge acquired by doctors in their training and may complicate the decision-making process.

Conditions

  • Non-resectable Metastatic Cancer of the Lung
  • Non-resectable Metastatic Cancer of the Colon
  • Non-resectable Metastatic Cancer of the Rectosigmoid Junction
  • Non-resectable Metastatic Cancer of the Stomach
  • Non-resectable Metastatic Cancer of the Bile Duct
  • Non-resectable Metastatic Cancer of the Rectum
  • Non-resectable Metastatic Cancer of Gastrointestinal Neuroendocrine Tumour
  • Non-resecable Metastatic Cancer of the Pancreas

Interventions

OTHER

Interviews

Semi-directed interviews, recorded and transcribed for analysis

OTHER

Questionnaires

economic and psycho-social questionnaires

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-19
Primary Completion
2020-12-09
Completion
2020-12-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328065 on ClinicalTrials.gov